Adile Orhan

2.4k total citations · 1 hit paper
24 papers, 1.5k citations indexed

About

Adile Orhan is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Adile Orhan has authored 24 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 7 papers in Surgery and 5 papers in Immunology. Recurrent topics in Adile Orhan's work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Surgical Treatments (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (4 papers). Adile Orhan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Surgical Treatments (4 papers) and Cardiac, Anesthesia and Surgical Outcomes (4 papers). Adile Orhan collaborates with scholars based in Denmark, United States and Netherlands. Adile Orhan's co-authors include Ismail Gögenür, Hans Raskov, Jan Pravsgaard Christensen, Michael Tvilling Madsen, Rasmus Peuliche Vogelsang, Ali Salanti, Christian Nolsøe, Anne‐Marie Kanstrup Fiehn, Hannelouise Kissow and Jens Ole Eriksen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Annals of Surgery.

In The Last Decade

Adile Orhan

22 papers receiving 1.5k citations

Hit Papers

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy 2020 2026 2022 2024 2020 250 500 750 1000

Peers

Adile Orhan
Adile Orhan
Citations per year, relative to Adile Orhan Adile Orhan (= 1×) peers Yanyan Han

Countries citing papers authored by Adile Orhan

Since Specialization
Citations

This map shows the geographic impact of Adile Orhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adile Orhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adile Orhan more than expected).

Fields of papers citing papers by Adile Orhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adile Orhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adile Orhan. The network helps show where Adile Orhan may publish in the future.

Co-authorship network of co-authors of Adile Orhan

This figure shows the co-authorship network connecting the top 25 collaborators of Adile Orhan. A scholar is included among the top collaborators of Adile Orhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adile Orhan. Adile Orhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Orhan, Adile, et al.. (2024). Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. Expert Opinion on Drug Metabolism & Toxicology. 20(6). 473–489. 4 indexed citations
4.
Raskov, Hans, Adile Orhan, Mette Ø. Agerbæk, & Ismail Gögenür. (2024). The impact of platelets on the metastatic potential of tumour cells. Heliyon. 10(14). e34361–e34361. 4 indexed citations
5.
Orhan, Adile, et al.. (2024). Insights Into the Group of Surgically Resectable But Nonoperable Patients With Colorectal Cancer. Diseases of the Colon & Rectum. 68(3). 351–358.
6.
Orhan, Adile, et al.. (2024). Introducing Neoadjuvant Immunotherapy for Colorectal Cancer. Annals of Surgery. 281(1). 95–104. 3 indexed citations
7.
Orhan, Adile, et al.. (2023). Myocardial injury and long-term oncological outcomes in patients undergoing surgery for colorectal cancer. International Journal of Colorectal Disease. 38(1). 234–234. 2 indexed citations
8.
9.
Vogelsang, Rasmus Peuliche, Mustafa Bulut, Mikail Gögenur, et al.. (2023). Neoadjuvant calcium electroporation for potentially curable colorectal cancer. Surgical Endoscopy. 38(2). 697–705. 1 indexed citations
10.
Raskov, Hans, et al.. (2023). The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer. Cancers. 15(7). 2057–2057. 8 indexed citations
11.
Raskov, Hans, et al.. (2022). Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy. Oncogenesis. 11(1). 22–22. 54 indexed citations
12.
Raskov, Hans, et al.. (2022). Metabolic switch in cancer – Survival of the fittest. European Journal of Cancer. 180. 30–51. 12 indexed citations
14.
Orhan, Adile, et al.. (2022). Electroporation and Immunotherapy—Unleashing the Abscopal Effect. Cancers. 14(12). 2876–2876. 40 indexed citations
15.
Raskov, Hans, et al.. (2021). Natural Killer Cells in Cancer and Cancer Immunotherapy. Cancer Letters. 520. 233–242. 25 indexed citations
16.
Raskov, Hans, et al.. (2021). Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy. Frontiers in Oncology. 11. 668731–668731. 94 indexed citations
17.
Vogelsang, Rasmus Peuliche, Rasmus Dahlin Bojesen, Adile Orhan, et al.. (2021). Prediction of 90-day mortality after surgery for colorectal cancer using standardized nationwide quality-assurance data. BJS Open. 5(3). 15 indexed citations
18.
Raskov, Hans, Adile Orhan, Jan Pravsgaard Christensen, & Ismail Gögenür. (2020). Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. British Journal of Cancer. 124(2). 359–367. 1035 indexed citations breakdown →
19.
Orhan, Adile, et al.. (2020). The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. European Journal of Cancer. 132. 71–84. 112 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026